Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness, safety, tolerability and best
dose of Lapatinib (GW572016) in combination with carboplatin and paclitaxel.